416 related articles for article (PubMed ID: 29462108)
1. Disulfiram attenuates morphine or methadone withdrawal syndrome in mice.
de Cordé A; Krząścik P; Wolińska R; Kleczkowska P; Filip M; Bujalska-Zadrożny M
Behav Pharmacol; 2018 Aug; 29(5):393-399. PubMed ID: 29462108
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.
Singh P; Sharma B; Gupta S; Sharma BM
Psychopharmacology (Berl); 2015 Jan; 232(2):465-75. PubMed ID: 25059539
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
4. Effects of tizanidine administration on precipitated opioid withdrawal signs in rats.
Pinelli A; Trivulzio S; Spezia R
Drug Alcohol Depend; 1998 Mar; 50(1):81-8. PubMed ID: 9589275
[TBL] [Abstract][Full Text] [Related]
5. Quantitative evaluation of opioid withdrawal signs in rats repeatedly treated with morphine and injected with naloxone, in the absence or presence of the antiabstinence agent clonidine.
Pinelli A; Trivulzio S
J Pharmacol Toxicol Methods; 1997 Nov; 38(3):117-31. PubMed ID: 9523765
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide trefoil factor 3 attenuates naloxone-precipitated withdrawal in morphine-dependent mice.
Wu P; Shi HS; Luo YX; Zhang RX; Li JL; Shi J; Lu L; Zhu WL
Psychopharmacology (Berl); 2014 Dec; 231(24):4659-68. PubMed ID: 24825609
[TBL] [Abstract][Full Text] [Related]
7. Probing different paradigms of morphine withdrawal on sleep behavior in male and female C57BL/6J mice.
Bedard ML; Lord JS; Perez PJ; Bravo IM; Teklezghi AT; Tarantino LM; Diering GH; McElligott ZA
Behav Brain Res; 2023 Jun; 448():114441. PubMed ID: 37075956
[TBL] [Abstract][Full Text] [Related]
8. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
[TBL] [Abstract][Full Text] [Related]
9. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
Azizi H; Ranjbar-Slamloo Y; Semnanian S
Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
[TBL] [Abstract][Full Text] [Related]
10. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
Sinchaisuk S; Ho IK; Rockhold RW
Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
[TBL] [Abstract][Full Text] [Related]
11. Differential modification of morphine and methadone dependence by interferon alpha.
Dougherty PM; Pearl J; Krajewski KJ; Pellis NR; Dafny N
Neuropharmacology; 1987 Nov; 26(11):1595-600. PubMed ID: 3431662
[TBL] [Abstract][Full Text] [Related]
12. Matricaria chamomilla extract inhibits both development of morphine dependence and expression of abstinence syndrome in rats.
Gomaa A; Hashem T; Mohamed M; Ashry E
J Pharmacol Sci; 2003 May; 92(1):50-5. PubMed ID: 12832855
[TBL] [Abstract][Full Text] [Related]
13. Ondansetron Does Not Reduce Withdrawal in Patients With Physical Dependence on Chronic Opioid Therapy.
Chu LF; Sun J; Clemenson A; Erlendson MJ; Rico T; Cornell E; Obasi H; Sayyid ZN; Encisco EM; Yu J; Gamble JG; Carroll I; Clark JD
J Addict Med; 2017; 11(5):342-349. PubMed ID: 28514235
[TBL] [Abstract][Full Text] [Related]
14. Morphine restores and naloxone-precipitated withdrawal depresses wheel running in rats with hindpaw inflammation.
Morgan MM; Ataras K
Pharmacol Biochem Behav; 2021 Oct; 209():173251. PubMed ID: 34363827
[TBL] [Abstract][Full Text] [Related]
15. Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.
Walker EA; Sterious SN
Br J Pharmacol; 2005 Aug; 145(7):975-83. PubMed ID: 15912139
[TBL] [Abstract][Full Text] [Related]
16. Orphanin FQ/nociceptin inhibits morphine withdrawal.
Kotlińska J; Suder P; Legowska A; Rolka K; Silberring J
Life Sci; 2000 Jan; 66(8):PL119-23. PubMed ID: 10680585
[TBL] [Abstract][Full Text] [Related]
17. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence.
Kest B; Palmese CA; Hopkins E; Adler M; Juni A; Mogil JS
Neuroscience; 2002; 115(2):463-9. PubMed ID: 12421612
[TBL] [Abstract][Full Text] [Related]
18. Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome.
Rehni AK; Singh N; Rachamalla M; Tikoo K
Naunyn Schmiedebergs Arch Pharmacol; 2012 Jun; 385(6):605-19. PubMed ID: 22362134
[TBL] [Abstract][Full Text] [Related]
19. Comparative study in mice of flunitrazepam vs. diazepam on morphine withdrawal syndrome.
Gibert-Rahola J; Maldonado R; Micó JA; Leonsegui I; Saavedra MC
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):927-33. PubMed ID: 3241876
[TBL] [Abstract][Full Text] [Related]
20. micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal.
Madhavan A; He L; Stuber GD; Bonci A; Whistler JL
J Neurosci; 2010 Mar; 30(9):3276-86. PubMed ID: 20203187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]